Gleason Shane Thomas 4

What Happened

• Shane Thomas Gleason, Chief Commercial Officer of InspireMD (NSPR), reported multiple open‑market sales (all "S" transactions) totaling 85,295 shares for aggregate proceeds of approximately $189,596. Sales occurred across multiple dates between Jan 27, 2025 and May 19, 2026 at prices ranging roughly from $1.00 to $3.65 per share.
• These sales were reported as sell‑to‑cover transactions to satisfy tax withholding on vesting restricted stock (see footnote F1), not discretionary market trades.

Key Details

• Transaction dates: Jan 27, 2025 → May 19, 2026. Representative trades include: 10,000 shares @ $3.65 (Feb 25, 2025) and 22,778 shares @ $1.01 (May 19, 2026).
• Price range: approximately $1.00–$3.65; one weighted‑average sale (May 19, 2026) reported at $1.01 with individual trade prices in the $1.00–$1.04 range (footnote F2).
• Shares sold: 85,295; Total proceeds: ≈ $189,596.
• Shares owned after transaction: Not provided in the supplied filing details.
• Footnotes: F1 — sales were automatic sell‑to‑cover for tax withholding (not discretionary). F2 — weighted average price disclosed for the May 19, 2026 sale; breakdown by individual prices available on request.
• Timeliness: Form filed May 21, 2026. Several 2025 sales were reported well after the trade dates, indicating late reporting for those earlier transactions.

Context

• Sell‑to‑cover transactions are routine when restricted stock vests and the issuer or insider sells shares to cover payroll/tax withholding; they do not necessarily indicate a change in the insider’s market view.
• For retail investors, purchases by insiders tend to be more informative about confidence in the company; routine tax‑related sales are common and should be interpreted accordingly.